- Ongoing, recruitingTherapeutic exploratory (Phase II)
PICASSO. Prospective randomIzed clinical trial assessing the tolerance and clinical benefit of feCAl tranSplantation in patientS with melanOma treated with CTLA-4 and PD-1 inhibitors
This study, called PICASSO, is looking at a new treatment called MaaT013 for advanced melanoma. It aims to see how safe MaaT013 is when given alongside standard cancer drugs and if it can help patients live longer and respond better to treatment.
For: MelanomaFrance - AuthorisedTherapeutic exploratory (Phase II)
SGL-TX-PTDM: SGLT2i effect on PTDM development and kidney allograft function in kidney transplant recipients: A randomized, double-blind, placebo controlled, national multicenter trial
This study looks at how a drug called Forxiga affects new diabetes and kidney health in people who've had a kidney transplant. It compares Forxiga to a dummy pill to see if it makes a difference over 6 to 12 months.
For: Kidney transplant recipientsDenmark